Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹61.3 LQualified Make: NOVONORDISK
Model: NOVONORDISK 1000 IU
Title: INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII -- 1000 IU C 13 1 BASEMENT 2ND FLOOR 3RD FLOOR BLOCK C WAZIRPUR WAZIRPUR INDUSTRIAL AREA NORTH WEST DELHI DELHI 110052 | NORTH DELHI | DELHI | 110052 | Make: NOVONORDISK
Model: NOVONORDISK 1000 IU
Title: INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII -- 1000 IU | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
₹1.9 L
Closing Date
12 Dec 2023, 12:00 pmClosed
INJECTION RECOMBINANT HUMAN COAGULATION FACTOR
5667709
GEM/2023/B/4273755
Two Packet Bid
INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII -- 1000 IU
GeM Contract
15 days
Delhi; West Delhi
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to A. C. SURGIPHARMA PRIVATE LIMITED
₹61.3 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| INJECTION RECOMBINANT HUMAN COAGULATION FACTOR VIII --1000 IU | NOVONORDISK / NOVONORDISK 1000 IU | HSN not specified by seller | 900 vials | 6,814.5 | 6,133,050 |
7 documents required · 7 mandatory
2 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| INJECTION RECOMBINANT HUMAN COAGULATION FACTOR | Vivek Kumar 110015,ESIC MODELHOSPITAL BASAIDARAPUR NEW DELHI | 900 | 15 days |
₹1.9 L
16 Dec 2023
2 Dec 2023
12 Dec 2023
contract_GEMC-511687704380520.pdf
GEM_CONTRACT • 0.06 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5667709.pdf
GEM_BID
1000iu_2023-11-30-15-28-51_3e89eece8316878d196c0a71b42e28c8.pdf
SPECIFICATION
1701411578.pdf
OTHER
1701411571.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .